Related Experiment Video

Updated: Aug 14, 2026

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

Flare in neuropathy following rituximab therapy for Waldenstrom's macroglobulinemia

Vanita Noronha, Thomas M Fynan, Thomas Duffy

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|December 31, 2005

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

MRI radiomics-based predictive modeling for risk stratification and prognostication in oral tongue carcinoma.

Frontiers in oncology·2026

Randomized trial of adjuvant 5-FU-platinum vs paclitaxel-platinum for high-risk penile cancer.

Journal of the National Cancer Institute·2026

KRAS-Targeted Therapies in NSCLC: Resistance, Combination Strategies, and Emerging Clinical Paradigms.

Medical oncology (Northwood, London, England)·2026

Lessons learned from the use of capecitabine-based triplet neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2026

Prognostic Reclassification and Survival Outcomes in Intermediate-Risk and Poor-Risk Nonseminomatous Germ Cell Tumors: Single-Institution Experience From Western India.

JCO global oncology·2026

Immuno-oncology in the perioperative setting: the next frontier in resectable head and neck cancers - a systematic review.

BMC cancer·2026

See all related articles